Integra LifeSciences stock falls after sharp slide, valuation debate grows

Published on 09/18/2026 at 14:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Integra LifeSciences stock closed at USD 15.10 on September 17, 2026, down 6.1 percent and near the lower end of its 52-week range. The move comes as one portal sees the shares 26.4 percent below estimated fair value while consensus still points to limited upside.

IART, US4579851036, Illustration mit AI erstellt.

Integra LifeSciences Holdings Corporation stock (ISIN US4579851036) closed at USD 15.10 on the Nasdaq on September 17, 2026, after a 6.1 percent decline that pushed the shares closer to the lower end of their 52-week range between USD 8.70 and USD 20.49.

Stock under pressure in September

According to GuruFocus on September 17, 2026, Integra LifeSciences shares fell 6.1 percent on that day to a closing price of USD 15.10, leaving the stock just above its 52-week low of USD 8.70 and clearly below the 52-week high of USD 20.49.

The same overview notes that the shares are up 21.6 percent year to date but down 14.5 percent over the past month, illustrating how the recent slide has erased a significant part of the earlier recovery.GuruFocus

Valuation picture and analyst stance

In its valuation model, GuruFocus assigns a GF Value estimate of USD 20.53 for Integra LifeSciences, compared with the current price of USD 15.10, implying the shares trade about 26.4 percent below that internal fair value gauge.

By contrast, a recent alert from MarketBeat on September 17, 2026, states that the company carries a consensus rating of Reduce and a consensus target price of USD 18.86, suggesting more cautious expectations and a narrower implied upside from the prevailing market price.

This creates a clear quantitative tension for investors: while the GF Value framework points to more than 5 dollars per share potential versus the USD 15.10 close, the analyst consensus embedded in the USD 18.86 target indicates only about 24.9 percent upside and still frames the stock as one to underweight.

Recent trading metrics and investor perspective

Per data cited by Yahoo Finance, Integra LifeSciences shares stood at USD 15.10 at the close on September 17, 2026, with an indicated pre-market price of USD 15.20 early on September 18, 2026, which would represent a modest 0.66 percent uptick versus the prior close if sustained.

For investors, the recent pattern means the stock now trades closer to the lower half of its USD 8.70 to USD 20.49 52-week corridor, with the USD 15.10 closing level sitting roughly 26 percent below the GF Value estimate and about 19.9 percent below the USD 18.86 consensus target mentioned by MarketBeat.

Stock price as of the latest close

Integra LifeSciences stock last closed at USD 15.10 on the Nasdaq on September 17, 2026, with a day loss of 6.1 percent from the previous session and trading within a 52-week range of USD 8.70 to USD 20.49.